In a recent study, Fabre and colleagues characterized the expression, localization, and phenotypic and molecular effects of MALINC1 in noninvasive and invasive BC cells and found that MALINC1 was modulated by the estrogen receptor (ER) in luminal cells. Here, ESR1 is linked to breast cancer.